Skip to main content

Table 1 Clinical characteristics of the child patients for this study

From: Endotoxin and CD14 in the progression of biliary atresia

  Con-C Early stage of BA OPD Late stage of BA CC
  Plasma Plasma Liver Plasma Plasma Liver Plasma & Liver
Sample No 7 41 9 25 49 9 9
Age (months) 18 ± 24 2.4 ± 1.2 2 ± 1 24 ± 16 15 ± 10 15 ± 6 22 ± 14
Sex (M/F) 4/3 23/16 4/5 7/18 19/21 4/5 2/7
AST (U/l) ND 200 ± 175 181 ± 130 ND 276 ± 241 246 ± 114 298 ± 228
T. Bil (mg/dl) ND 9.0 ± 2.9 9.4 ± 3.0 ND 16 ± 1.0 18 ± 10 6.5 ± 6.0
D. Bil (mg/dl) ND 6.3 ± 2.0 7.0 ± 2.3 ND 12 ± 7.5 13 ± 7.2 5.6 ± 4.0
sCD14 (μg/ml) 4.0 ± 0.8 4.7 ± 1.7 47 ± 14 4.2 ± 1.4 2.7 ± 1.5* 49 ± 12 4.0 ± 2.0
Endotoxin (EU/ml) 2.0 ± 1.0 6.2 ± 5.0* 17 ± 4.0 2.2 ± 5.0 6.7 ± 5.0* 16 ± 7.0 6.5 ± 4.0*
  1. Con-C, control-children; Early stage of BA, Kasai's procedure for biliary atresia; OPD, Jaundice-free post-Kasai BA patients followed at the outpatient department; Late stage of BA, liver transplantation for biliary atresia; CC, choledochal cyst; AST, alanine aminotransferase; D. Bil, direct bilirubin; T. Bil, total bilirubin; ND, non detection; sCD14, souble CD14; y, years. Value are expressed as the mean ± SD. *P < 0.05 vs control; P < 0.05 vs late stage of BA; P < 0.05 vs OPD.